The complex relationship between adenosine, obesity and Type 2 Diabetes (T2D) prompted us to investigate a possible role of genetic variability within adenosine deaminase (ADA) gene in the susceptibility to T2D in obese subjects. With enzymatic activity ADA contributes to the regulation of adenosine concentration in body fluids and as ecto-enzyme modulates signaling events involving adenosine receptors on cell surface.
INTRODUCTION
Several experimental observations suggest a complex relationship among adenosine, obesity and type 2 diabetes. An increase of adenosine A1 receptor activity is associated with obesity in T2D [1] [2] [3] and we have found an association between adenosine deaminase locus 1 (ADA 1 ) genetic polymorphism and Body Mass Index (BMI) in T2D [4] . Adenosine may increase the sensitivity to insulin in adipose tissue [5] [6] [7] and in obese subjects a decrease of A1 receptors number has been reported [8] . Adenosine deaminase (ADA) controls the irreversible deamination of adenosine to inosine contributing to the regulation of adenosine concentration in body fluids.
The biochemical genetic polymorphism of ADA was discovered in 1968 by Harris group [9] who identified by starch gel electrophoresis three common genotypes determined by the presence of two codominant alleles ADA 1 *1 and ADA 1 *2 at an autosomal locus. ADA 1 *1 is more enzymatically active as compared to ADA 1 *2.
The structure of ADA gene has been elucidated by Viginton et al. in 1986 [10] . The gene is localized on chromosome 20q13.11 and is composed by 12 exons spanning about 32 Kb of DNA. Several polymorphic loci have been identified within exonic and intronic regions of the gene [11] . The possible relationship between this genetic variability and human diseases is at present unknown. Besides the enzymatic function in deamination of adenosine, ADA acts also as ectoenzyme contributing to the degradation of extra cellular adenosine and interacting with the anchoring proteins CD26 and A 1 R facilitates signaling events [12, 13] .
In the present note we have studied the role of ADA genetic variability in the relationship between obesity and T2D in a sample of subjects admitted to the Hospital for cardiovascular diseases. The high susceptibility to T2D in obese subjects is well known: many obese subjects, however, do not become diabetic while non obese subjects may become diabetic suggesting that genetic factors have an important role in the relationship between obesity and diabetes. Indeed we have recently reported an effect of p53 codon 72 polymorphism on the susceptibility to Type 2 Diabetes in overweight subjects [14] .
We have examined three single nucleotide polymorphisms (SNPs) within the ADA gene: ADA 1 (Taq 1 site nt 4050-4053) on exon 1 corresponding to the biochemical genetic polymorphism described by the group of Harris in 1968; ADA 2 (Pst 1 site nt 19465-19470) localized on intron 2 and ADA 6 (MluNI site nt 31230-31235) localized on exon 6.
MATERIAL AND METHODS
We have studied 299 subjects from the White population of Rome admitted consecutively to the Hospital for cardiovascular diseases. These patients have been considered also in previous studies [14] . Verbal consent was obtained by the patients to participate to the study that was approved by the council of department. The data have been collected a few years ago, before the establishment of an Ethical Committee. All procedures followed were in accordance with the ethical standards and with the Helsinki Declaration of 1964 and its later amendments.
Genotypes of ADA 1 , ADA 2 and ADA 6 were determined by DNA analysis as previously described [15] . Statistical analyses were performed by commercial software (SPSS) [16] . The number of subjects is not exactly the same in all tables because of random loss of some genotype determination among the loci considered. Eta(η) is a measure of the strength of association between two variables. Eta squared (η 2 )
represents the proportion of variance of dependent variable explained by the independent variable. Table 1 shows some demographic data on the subjects studied. Table 2 shows the relative risk to become diabetic in obese subjects vs non obese subjects in relation to homozygosity for ADA 1 , ADA 2 and ADA 6 polymorphisms. For all ADA sites the relative risk to become diabetics is higher in homozygous subjects for the more common allele than in carriers of the less frequent allele. Table 3 shows the relationship between the number of homozygous genotypes for the more frequent allele in the three ADA loci and the relative risk to become diabetics in obese subjects vs non obese subjects. Odds ratio and strength of association between obesity and T2D increases with the number of homozygous genotypes. Three-way contingency table analysis by a log linear model shows a statistically significant interaction among diabetes, BMI and ADA suggesting that the association between obesity and diabetes depends on ADA genotype. The analysis also shows a significant cooperative effect of ADA and obesity on the susceptibility to diabetes: the strength of association between ADA and diabetes, however, is lower as compared to the strength of association between obesity and diabetes.
RESULTS
We have analyzed the effect of sex and age (≤65 years' vs > 65 years) on the relationship between genetic variability of ADA gene and susceptibility to diabetes in obese subjects Odds Ratio diabetics vs non diabetics/ BMI>30 vs BMI ≤ 30 is always higher in carriers of homozygous genotypes in the three loci than in other subjects.
DISCUSSION AND CONCLUSION
The data suggest a relationship between genetic variability within the ADA gene and susceptibility to T2D in obese subjects. The susceptibility appears negatively correlated with the number of loci in which is present the variant with low frequency suggesting an heterozygote advantage in the protection of obese subjects from diabetes. The mechanism underlying this advantage has to be elucidated. If confirmed in other clinical settings, our observation could allow to assign a higher risk of diabetes to obese subjects who are homozygous for the major allele in all the three loci of ADA gene. ADA 1 is an exonic polymorphism associated with quantitative variation of enzymatic activity. ADA 2 is an intronic polymorphism and ADA 6 is an exonic polymorphism characterized by a synonymous substitution, which does not change the protein sequence but could influence tissue specific expression. ADA 2 and ADA 6 could be in linkage disequilibrium with ADA sites directly responsible for the association observed. Indeed the analysis of linkage disequilibrium within the ADA gene performed by Cruciani et al. [17] has shown areas of weak association and areas of strong association between pairs of internal markers.
The correlation between obesity and diabetes is stronger in subjects homozygous for the more frequent allele in all the three loci examined than in other subjects. It is possible that the three loci directly or indirectly control different mechanisms involved in the susceptibility to diabetes in obese subjects: the maximum risk is attained when the three mechanisms operate simultaneously.
Further investigations on the role of ADA in the susceptibility to T2D in obese subjects would be rewarding. The limitations of our study are represented by the relatively small number of subjects examined and by the fact that it has been carried out on a sample of subjects admitted to the hospital for cardiovascular diseases and this could have introduced some nonidentified bias.
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